07:39 AM EDT, 05/08/2025 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Q1 net income Thursday of $238 million, up from $5 million a year earlier.
Total income and other revenue for the quarter ended March 31 was $568 million, unchanged from a year earlier.
Analyst estimates were not readily available for comparison.